Pressroom: Media Coverage

Showing 581 - 600 of 610 news items

2011

Drug Dramatically Helps Melanoma Patients

According to research led by investigators at Memorial Sloan Kettering Cancer Center, two new drugs — vemurafenib and ipilimumab (Yervoy™) — were found to prolong the lives of patients with advanced melanoma, one of the deadliest forms of skin cancer. Medical oncologist Paul Chapman and Jedd Wolchok (vemurafenib )are quoted.

June 5, 2011
Drugs Show Promise Slowing Advanced Melanoma

According to research led by investigators at Memorial Sloan Kettering Cancer Center, two new drugs — vemurafenib and ipilimumab (Yervoy™) — were found to prolong the lives of patients with advanced melanoma, one of the deadliest forms of skin cancer. Medical oncologist Paul Chapman and Jedd Wolchok (vemurafenib )are quoted.

June 5, 2011
Removing a Brain Tumor

Neurosurgeon Philip Gutin discusses one of his recent brain surgery cases.

June 5, 2011
Best Doctors 2011

Seventy-one doctors from Memorial Sloan Kettering Cancer Center were listed among New York Magazine’s 2011 Best Doctors list.

June 5, 2011
Matching Cancer Drugs to Gene Mutations Raises Survival Odds

Doctors are treating cancer according to the genetic aberrations found in patients’ tumors, not just where they’re found in the body, an approach that may boost the odds of survival. Medical oncologist Leonard Saltz is quoted.

June 4, 2011
Cancer Cell Tests May Help Predict Drug Reaction

Two studies led by researchers at Memorial Sloan Kettering Cancer Center are part of the search for biological signals known as biomarkers that can predict which patients are the best match for drugs or give an early indication that treatments are working. Medical oncologists Howard Scher and Mark Kris are quoted.

June 4, 2011
Aromasin Cuts Risk of Breast Cancer in Some Groups

The estrogen-blocker exemestane (Aromasin®) was found to reduce the risk of developing breast cancer by 65 percent in postmenopausal women at high risk for breast cancer. Medical oncologist Andrew Seidman is quoted.

June 4, 2011
Roche's Avastin Delays Death by Slowing Growth of Ovarian Cancer

A study led by gynecologic oncologist Carol Aghajanian showed the drug bevacizumab (Avastin®) delayed the progression of advanced ovarian cancer. She is quoted in the article.

June 4, 2011
Woodbridge Man Celebrates Life After Cancer

A celebration was held at Memorial Sloan Kettering Cancer Center Basking Ridge to honor cancer survivors treated at the Center’s outpatient facility in New Jersey. Medical oncologist Han Xiao is quoted.

June 3, 2011
Scanxiety

Psycho-oncologist Jimmie Holland is quoted in an article about “scanxiety,” the stress that some cancer patients experience as their scan appointments approach.

June 2, 2011
CBS Evening News

Medical oncologist Eileen O’Reilly discusses how medical professionals can improve their communication with patients regarding end-of-life issues.

June 1, 2011
MSKCC Gets Nod For Eco-Practices

A “green team” from Memorial Sloan Kettering Cancer Center has spent the past two years developing ways for the hospital, with more than 11,000 employees in 40 locations, to become more energy efficient and reduce its waste. Hospital administrator Cynthia McCollum is quoted.

May 31, 2011
Why Medical School Should Be Free

The Bureau of Labor Statistics reports that of the 15 highest-paid professions in the United States, all but two are in medicine or dentistry. Why, then, are we proposing to make medical school free? Epidemiologist and pulmonary and critical care physician Peter Bach is co-author of this op-ed.

May 28, 2011
The Costly War on Cancer

Oncologists have long used the same blunt weapons to fight different types of cancer: cut the tumor out, zap it with radiation, or blast it with chemotherapy that kills good cells as well as bad ones. New cancer drugs are changing this. Epidemiologist and pulmonary and critical care physician Peter Bach is quoted.

May 26, 2011
Prostate Cancer Drug Zytiga May Extend Life

Abiraterone acetate (Zytiga™), which was approved in the United States in April, is the latest of several new treatment options available for patients with advanced prostate cancer. Medical oncologist Howard Scher is quoted.

May 25, 2011
Radiation for Hodgkin's Linked to Increased Mortality

Although breast cancer may be diagnosed earlier, women with who have received radiation therapy for the treatment of Hodgkin lymphoma are more likely to have bilateral breast cancer, and die due to other causes, according to a Memorial Sloan Kettering study published in the Journal of Clinical Oncology. Outcomes research scientist Elena Elkin commented on the study, which she authored.)

May 20, 2011
New Cervical Cancer Treatment Brings Hope to Women Looking to Bear Children

Surgical oncologist Dennis Chi discusses a radical trachelectomy — a procedure that aids in treating cervical cancer.

May 18, 2011
Death from Prostate Cancer May Be Predicted with Earlier and Fewer Tests

Prostate cancer screening beginning from ages 44 to 50 may rule out the risk of dying in half of men, according to a Memorial Sloan Kettering study that showed some men may need as few as three screening tests in a lifetime. The article quotes surgical oncologist Peter Scardino and clinical chemist Hans Lilja, both co-authors of the study.

May 18, 2011
Memorial Sloan Kettering Ranked in the Top Ten Best Children's Hospitals by US News & World Report

Memorial Sloan Kettering has been ranked among the top 10 in cancer in the 2011-12 Best Children’s Hospitals rankings — the only New York-area hospital in the top 15.

May 17, 2011
NY Children's Hospitals Rank Among Nation's Best

U.S. News & World Report ranked Memorial Sloan Kettering Cancer Center number seven among the top 50 best hospitals for pediatric cancer treatment in the nation.

May 17, 2011